Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: RESILIENCE GOVERNMENT SERVICES, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-06-16 to 2025-02-28
Current total value of award: $4861155.86
Description: U.S. FOOD AND DRUG ADMINISTRATION (FDA) LICENSED MONOCLONAL ANTIBODY  COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE CONTRACT EFFORT.